title: The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
abstract: Thrombin displays remarkable specificity, effecting the removal of fibrinopeptides A and B of fibrinogen through the selective cleavage of two Arg-Gly bonds between the 181 Arg/Lys-Xaa bonds in fibrinogen. Significant advances have been made in recent years towards understanding the origin of the specificity of cleavage of the Arg16-Gly17 bond of the A alpha-chain of human fibrinogen. We have previously proposed a model for the bound structure of fibrinopeptide A7-16 (FPA), based upon NMR data, computer-assisted molecular modeling and the synthesis and study of peptidomimetic substrates and inhibitors of thrombin. We now report the structure of the ternary complex of an FPA mimetic (FPAM), hirugen and thrombin at 2.5 A resolution (R-factor = 0.138) and specificity data for the inhibition of thrombin and related trypsin-like proteinases by FPAM. The crystallographic structures of FPA and its chloromethyl ketone derivative bound to thrombin were determined. Although there are differences between these structures in the above modeled FPA structure and that of the crystal structure of FPAM bound to thrombin, the phi, psi angles in the critical region of P1-P2-P3 in all of the structures are similar to those of bovine pancreatic trypsin inhibitor (BPTI) in the BPTI-trypsin complex and D-Phe-Pro-Arg (PPACK) in the PPACK-thrombin structure. A comparison between these and an NMR-derived structure is carried out and discussed.
authors.affiliation: Michigan State University, Department of Chemistry, East Lansing 48824.
authors.forename: T P
authors.initials: TP
authors.lastname: Wu
authors.forename: V
authors.initials: V
authors.lastname: Yee
authors.forename: A
authors.initials: A
authors.lastname: Tulinsky
authors.forename: R A
authors.initials: RA
authors.lastname: Chrusciel
authors.forename: H
authors.initials: H
authors.lastname: Nakanishi
authors.forename: R
authors.initials: R
authors.lastname: Shen
authors.forename: C
authors.initials: C
authors.lastname: Priebe
authors.forename: M
authors.initials: M
authors.lastname: Kahn
mesh_terms: D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D001381:Azepines / Q000737:chemistry* / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism; D006629:Hirudins / Q000031:analogs & derivatives* / Q000737:chemistry; D008958:Models, Molecular; D008968:Molecular Conformation; D009842:Oligopeptides / Q000737:chemistry* / Q000494:pharmacology; D010446:Peptide Fragments / Q000737:chemistry*; D011487:Protein Conformation; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D013379:Substrate Specificity; D013917:Thrombin / Q000737:chemistry* / Q000378:metabolism; D014961:X-Ray Diffraction
chemical_list: D000590:Amino Acid Chloromethyl Ketones; D001381:Azepines; D006629:Hirudins; D009842:Oligopeptides; D010446:Peptide Fragments; D015842:Serine Proteinase Inhibitors; C062510:hirugen; C083476:alpha-(1,7-diaza-5-(alpha-(phenylmethylamino)phenylmethyl)-2,6-dioxobicyclo(5.4.0)undecan-8-yl)glycyl-isoleucyl-argininyl chloromethyl ketone; D005340:Fibrinogen; D013917:Thrombin; C040308:phenylalanyl-prolyl-arginine-chloromethyl ketone